Impact of the social context on the prognosis of Chagas disease patients: Multilevel analysis of a Brazilian cohort
Carregando...
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
FERREIRA, Ariela Mota
OLIVEIRA, Claudia Di Lorenzo
CARDOSO, Clareci Silva
RIBEIRO, Antonio Luiz Pinho
DAMASCENO, Renata Fiuza
NUNES, Maria do Carmo Pereira
HAIKAL, Desiree Sant' Ana
Citação
PLOS NEGLECTED TROPICAL DISEASES, v.14, n.6, 2020
Resumo
Author summary Chagas disease (CD) is a serious public health problem in Latin America and has a strong social impact worldwide. Up to 30% of the infected people may have cardiac alterations, which are associated with a worse prognosis and with high mortality rates. The occurrence of CD is associated with contexts of social vulnerability. However, no studies have been identified that assessed whether unfavorable social contexts are related to the prognosis and evolution of CD, which is the purpose of our study. We evaluated 1,637 patients with CD who lived in 21 municipalities located in regions to which CD is endemic in Brazil, over a two-year period. Of these people, 12.5% evolved into a worse prognosis. Our study revealed that socio-demographic and clinical characteristics of individuals were not isolated protagonists of the evolution of CD. The context in which individuals lived was also a determining factor of a worse prognosis, including living in municipalities with a smaller rural population, fewer physicians, and a smaller Primary Health Care (PHC) coverage. Thus, we observed that characteristics related to the health care available in the municipalities influenced the evolution of CD. This knowledge has the potential to support health care planning that is more appropriate for the evolution of patients with CD, especially considering poor and remote regions. The present study aims to investigate how the social context contributes to the prognosis of Chagas disease (CD). This is a multilevel study that considered individual and contextual data. Individual data came from a Brazilian cohort study that followed 1,637 patients who lived in 21 municipalities to which CD is endemic, over two years. Contextual data were collected from official Brazilian government databases. The dependent variable wasthe occurrence of cardiovascular events in CDduring the two-year follow-up, defined from the grouping of three possible combined events: death, development of atrial fibrillation, or pacemaker implantation. Analysis was performed using multilevel binary logistic regression. Among the individuals evaluated, 205 (12.5%) manifested cardiovascular events in CD during two years of follow-up. Individuals living in municipalities with a larger rural population had protection for these events (OR = 0.5; 95% CI = 0.4-0.7), while those residing in municipalities with fewer physicians per thousand inhabitants (OR = 1.6; 95% CI = 1.2-2.5) and those living in municipalities with lower Primary Health Care (PHC) coverage (OR = 1.4; 95% CI = 1.1-2.1) had higher chances of experiencing cardiovascular events. Among the individual variables, the probability of experiencing cardiovascular events was higher for individuals aged over 60 years (OR = 1.4; 95% CI = 1.01-2.2), with no stable relationship (OR = 1.4; 95% CI = 0.98-2.1), without previous treatment with Benznidazole (OR = 1.5; 95% CI = 0.98-2.9), with functional class limitation (OR = 2.0; 95% CI = 1.4-2.9), with a QRS complex duration longer than 120 ms (OR = 1.5; 95% CI = 1.1-2.3), and in individuals with high NT-proBNP levels (OR = 6.4; 95% CI = 4.3-9.6). CONCLUSION: The present study showed that the occurrence of cardiovascular events in individuals with CD is determined by individual conditions that express the severity of cardiovascular involvement. However, these individual characteristics are not isolated protagonists of this outcome, and the context in which individuals live, are also determining factors for a worse clinical prognosis.
Palavras-chave
Referências
- Alkmim MB, 2012, B WORLD HEALTH ORGAN, V90, P373, DOI 10.2471/BLT.11.099408
- Andersen R, 2007, CHANGING US HLTH CAR, P3
- [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33
- [Anonymous], 2005, CYBERPSYCHOL BEHAV, V8, P7
- [Anonymous], 2018, CIRCULATION, V138, pe751, DOI 10.1161/CIR.0000000000000636
- Ayres JRCM, 2009, PROMOCAO SAUDE
- Barreto SM, 2013, REV SAUDE PUBL, V47, P79, DOI 10.1590/S0034-8910.2013047003836
- Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558
- Borde E, 2014, CAD SAUDE PUBLICA, V30, P2081, DOI 10.1590/0102-311X00162513
- Brasil. Ministerio da Saude, 1997, SAUD FAM ESTR REOR M
- Camm AJ, 2013, EUR HEART J, V34, P2850
- Capuani L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005542
- Cardoso CS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006814
- Cardoso CS, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011181
- CHACKO KA, 1995, CIRCULATION, V92, P2003
- Cucunuba ZM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1315-x
- Ferreira AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165950
- Francisco Priscila Maria Stolses Bergamo, 2011, Rev. bras. epidemiol., V14, P5, DOI 10.1590/S1415-790X2011000500002
- Freitas HFG, 2005, INT J CARDIOL, V102, P239, DOI 10.1016/j.ijcard.2004.05.025
- Johnson NJ, 2000, ANN EPIDEMIOL, V10, P224, DOI 10.1016/S1047-2797(99)00052-6
- Kennedy BP, 1996, BRIT MED J, V312, P1004, DOI 10.1136/bmj.312.7037.1004
- Lima-Costa MF, 2010, AM J EPIDEMIOL, V172, P190, DOI 10.1093/aje/kwq106
- Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014
- Malta DC, 2016, CIENC SAUDE COLETIVA, V21, P327, DOI 10.1590/1413-81232015212.23602015
- Mamas MA, 2009, EUR J HEART FAIL, V11, P676, DOI 10.1093/eurjhf/hfp085
- Martinelli Filho Martino, 2003, Arq. Bras. Cardiol., V81, P2, DOI 10.1590/S0066-782X2003002000002
- Martins-Melo FR, 2019, INT J PARASITOL, V49, P301, DOI 10.1016/j.ijpara.2018.11.008
- Mendes EV, 2012, CUIDADO CONDICOES CR
- Morillo CA, 2015, NEW ENGL J MED, V373, P1295, DOI 10.1056/NEJMoa1507574
- Murphy M, 2007, POP STUD-J DEMOG, V61, P287, DOI 10.1080/00324720701524466
- Nadruz W, 2018, HEART, V104, P1522, DOI 10.1136/heartjnl-2017-312869
- OMS-OrganizacAo Mundial Da Saude, 2011, C MUND DET SOC SAUD
- OMS-OrganizacAo Mundial Da Saude . Departamento de Recursos Humanos para a Saude, 2009, DEP REC HUM SAUD
- Pastore CA, 2016, ARQ BRAS CARDIOL, V107, P392, DOI 10.5935/abc.20160173
- Nunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046
- Nunes MDP, 2010, REV ESP CARDIOL, V63, P788, DOI 10.1016/S0300-8932(10)70181-0
- Dias JCP, 2016, EPIDEMIOL SERV SAUDE, V25, P7, DOI [10.5123/S1679-49742016000500002, 10.5123/s1679-49742016000500002]
- Rassi Salvador, 2005, Arq. Bras. Cardiol., V84, P309, DOI 10.1590/S0066-782X2005000400007
- Ribeiro AL, 2012, NAT REV CARDIOL, V9, P576, DOI 10.1038/nrcardio.2012.109
- Ribeiro ALP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000632
- Ribeiro ALP, 2008, J CARDIOVASC ELECTR, V19, P502, DOI 10.1111/j.1540-8167.2007.01088.x
- Sabino EC, 2013, CIRCULATION, V127, P1105, DOI 10.1161/CIRCULATIONAHA.112.123612
- Scheffer M., 2018, DEMOGRAFIA MED BRASI
- Shi L, 1992, J Health Care Poor Underserved, V3, P321
- Shi L, 2004, J EPIDEMIOL COMMUN H, V58, P374, DOI 10.1136/jech.2003.013078
- Starfield B, 2001, BRIT J GEN PRACT, V51, P303
- Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7
- Braga JCV, 2008, INT J CARDIOL, V126, P276, DOI 10.1016/j.ijcard.2007.01.097
- WHO- World Health Organization, 2002, ARS CAS DET MAN SURV, P4